Indivior To Delist From LSE To Better Align With US Focused Business

(RTTNews) – Indivior PLC (INDV.L), a pharmaceutical company, said on Monday that it will cancel its secondary listing on the London Stock Exchange, or LSE, with effect from July 25. The company also noted that it will maintain its current primary listing on the Nasdaq.

admin